(Q37987099)

26 August 2017

Challenges for a universal Staphylococcus aureus vaccine (English)

1 reference

26 August 2017

Staphylococcus aureus

1 reference

1 reference

Richard A Proctor

1

1 reference

PubMed ID

22354924

26 August 2017

language of work or name

English

0 references

publication date

21 February 2012

1 reference

Clinical Infectious Diseases

26 August 2017

1 reference

26 August 2017

54

1 reference

26 August 2017

8

1 reference

26 August 2017

1179-1186

1 reference

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Staphylococcus aureus antigens and challenges in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Staphylococcal vaccines and immunotherapy: to dream the impossible dream?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Staphylococcal vaccines and immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

What is the best way to use conjugate vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

A humanized monoclonal antibody targeting Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Hematologically important mutations: X-linked chronic granulomatous disease (third update)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Immunity against Staphylococcus aureus cutaneous infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

The roles of IL-17A in inflammatory immune responses and host defense against pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

IL-17-producing T cells in lung immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Are B lymphocytes of importance in severe Staphylococcus aureus infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

The role of B cell CD22 expression in Staphylococcus aureus arthritis and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Management of community-acquired pneumonia: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

TLR2 signalling: At the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Role of lipoteichoic acid in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

How microorganisms avoid phagocyte attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Vaccine assembly from surface proteins of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Whooping cough outbreak hits several US states

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS033

21 January 2018

Identifiers

DOI

10.1093/CID/CIS033

1 reference

26 August 2017

1 reference

PubMed ID

22354924